These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9562711)

  • 1. [Malaria drug for African poor in sight].
    Knauer RH
    Fortschr Med; 1998 Mar; 116(7):12-4. PubMed ID: 9562711
    [No Abstract]   [Full Text] [Related]  

  • 2. Should chloroquine be laid to rest?
    Ginsburg H
    Acta Trop; 2005 Oct; 96(1):16-23. PubMed ID: 16054105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaria. Chloroquine makes a comeback.
    Vogel G
    Science; 2006 Nov; 314(5801):904. PubMed ID: 17095662
    [No Abstract]   [Full Text] [Related]  

  • 4. [Problems of malaria therapy].
    Schelp FP; Germer W
    Dtsch Med J; 1972 Aug; 23(8):529-32. PubMed ID: 4565047
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug resistance of Plasmodium and rational application of antimalarials].
    Liu DQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Oct; 23(5 Suppl):355-61. PubMed ID: 16562468
    [No Abstract]   [Full Text] [Related]  

  • 6. Chloroquine-resistant malaria.
    Wellems TE; Plowe CV
    J Infect Dis; 2001 Sep; 184(6):770-6. PubMed ID: 11517439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria. Signs of drug resistance rattle experts, trigger bold plan.
    Enserink M
    Science; 2008 Dec; 322(5909):1776. PubMed ID: 19095911
    [No Abstract]   [Full Text] [Related]  

  • 8. Biologic and geographic factors in prevention and treatment of malaria.
    Masinde GL; Krogstad DJ
    Curr Clin Top Infect Dis; 1994; 14():80-102. PubMed ID: 8086123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies.
    Laufer MK; Plowe CV
    Drug Resist Updat; 2004; 7(4-5):279-88. PubMed ID: 15533765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial drugs and their ways to use in the African milieu.
    Zoguéreh DD; Delmont J
    Sante; 2000; 10(6):425-33. PubMed ID: 11226940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
    Mengesha T; Makonnen E
    East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human transmission and plasmodium resistance].
    Le Bras J; Longuet C; Charmot G
    Rev Prat; 1998 Feb; 48(3):258-63. PubMed ID: 9781071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemisia annua as a self-reliant treatment for malaria in developing countries.
    de Ridder S; van der Kooy F; Verpoorte R
    J Ethnopharmacol; 2008 Dec; 120(3):302-14. PubMed ID: 18977424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making antimalarial agents available in Africa.
    Arrow KJ; Gelband H; Jamison DT
    N Engl J Med; 2005 Jul; 353(4):333-5. PubMed ID: 16000348
    [No Abstract]   [Full Text] [Related]  

  • 15. Urgent efforts needed to combat drug-resistant malaria.
    Wernsdorfer WH
    WHO Chron; 1983; 37(1):11-3. PubMed ID: 6613096
    [No Abstract]   [Full Text] [Related]  

  • 16. The biology of malaria parasites. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1987; 743():1-229. PubMed ID: 3109131
    [No Abstract]   [Full Text] [Related]  

  • 17. Rational approach to the treatment of malaria.
    Valecha N; Srivastava A; Sharma VP
    Natl Med J India; 1994; 7(6):281-7. PubMed ID: 7841881
    [No Abstract]   [Full Text] [Related]  

  • 18. Subacute clinical forms of Plasmodium falciparum malaria in travelers receiving chloroquine-proguanil prophylaxis.
    Klement E; Chauveheid MP; Thellier M; Bricaire F; Danis M; Caumes E
    Clin Infect Dis; 2001 Jul; 33(1):e1-2. PubMed ID: 11389510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalaria drug resistance: the mono-combi-counterfeit triangle.
    Schlagenhauf P; Petersen E
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1039-42. PubMed ID: 19883322
    [No Abstract]   [Full Text] [Related]  

  • 20. If artemisinin drugs fail, what's plan B?
    Enserink M
    Science; 2010 May; 328(5980):846. PubMed ID: 20466918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.